Creative Touch Permanent Makeup and Aesthetics

Skin is the body’s largest organ, covering approximately 1.5 to 2 square metres in adults and accounting for around 15% of total body weight. It performs functions that no topical product or professional treatment can replicate independently: regulating water loss, providing mechanical protection, moderating temperature, conducting immune surveillance, synthesising vitamin D, and sustaining the microbial ecosystem that contributes to immune homeostasis. For clinical and aesthetic purposes, it is best understood as three structurally distinct but functionally interdependent layers – the epidermis, dermis, and subcutaneous tissue – each of which ages through its own mechanisms whilst being continuously influenced by the others.

The visible and tactile signs of skin ageing are not a single process but the accumulated surface expression of multiple concurrent biological changes: barrier lipid depletion in the stratum corneum, filaggrin suppression disrupting the protein scaffold of the outer epidermis, slowing keratinocyte renewal reducing the differentiation quality of new barrier cells, fibroblast senescence and mechanosensitivity loss reducing collagen and elastin synthesis in the dermis, ground substance depletion removing the hydrated volume and fibroblast support environment, and MMP-driven degradation of structural proteins outpacing repair. Understanding which of these is dominant in a given presentation (rather than treating the surface uniformly) is the foundation of the approach taken across Creative Touch’s treatment and skincare guidance.

The Epidermis: Production System for the Barrier

The epidermis provides the barrier that makes terrestrial life physiologically possible, preventing the desiccation that would occur without it and regulating the immune and chemical gradient between the body and its environment. Its functional quality is determined by the keratinocyte differentiation programme that builds it: a continuous production process originating in dividing basal cells and culminating in the formation of the stratum corneum’s lamellar lipid matrix and protein-dense corneocytes.

This programme has two critical dependencies that become clinically relevant in aesthetic practice. First, it requires the ceramide, cholesterol, and free fatty acid precursors that lamellar body secretion depends on; the synthesis of which is suppressed by the same inflammatory cytokines that commonly underlie barrier dysfunction, sensitised skin, and atopic-tendency presentations. Second, it requires the profilaggrin-to-filaggrin processing that produces both the corneocyte protein scaffold and the natural moisturising factor components that maintain intracellular hydration and the acid mantle pH on which ceramide-processing enzymes depend. Both dependencies, and the downstream cascade when either fails, are covered in depth in the Ceramides, Free Fatty Acids, Cholesterol, and Filaggrin entities within this knowledge base.

The renewal rate of this production system slows measurably after the age of 50, and epidermal thickness declines alongside the ceramide and structural protein changes of hormonal transition, meaning the quality of what the epidermis produces and the pace at which it is produced both deteriorate simultaneously at the same life stage. ^[7]

The Dermis: Structural Foundation and Ageing Target

The dermis provides the structural support, vascular supply, and cellular machinery that skin appearance and mechanical behaviour depend on. Its fibroblasts synthesise collagen Types I and III, the fibrillin scaffold that supports elastic fibre assembly, and the hyaluronic acid and proteoglycans of the ground substance. All of these decline through converging processes: reduced fibroblast activity from cellular senescence and mechanical slack as the matrix degrades; increased MMP-driven degradation from UV exposure, cortisol elevation, and oestrogen decline; and the fibre fragmentation and disorganisation of solar elastosis that progressively replaces functional elastic tissue with non-functional accumulated material. ^[1]

The dermis also provides the structural context the epidermis requires. The dermo-epidermal junction, the fibroblast-to-keratinocyte TGF-β signalling that drives differentiation quality, the rete ridge architecture that physically anchors the epidermis and enables nutrient transfer, and the ground substance environment that sustains both populations – all are dermal properties that influence epidermal function as directly as the differentiation machinery within the epidermis itself. Treating the epidermis and dermis as independent concerns is a clinical oversimplification that the depth of this cross-layer biology does not support. ^[2]

How the Layers Interact in Ageing

The most clinically useful insight about skin ageing is that the epidermal and dermal mechanisms do not run in parallel, they amplify each other. Dermal collagen loss creates the mechanical slack that reduces fibroblast synthesis activity, which further accelerates collagen loss. Barrier dysfunction in the stratum corneum allows allergen penetration that drives the type 2 inflammatory cytokine activity that suppresses ceramide synthesis and filaggrin expression, worsening the barrier dysfunction that started the cycle. Reduced HA in the ground substance impairs the fibroblast environment, reducing the TGF-β and fibronectin production that supports the DEJ signalling that sustains keratinocyte differentiation quality above it. These feedback loops are why skin quality can appear to decline rapidly once a threshold is crossed, and why addressing a single layer or mechanism whilst leaving others unaddressed produces slower and less durable results. ^[3]

The convergence is particularly pronounced during perimenopause, when oestrogen decline reduces ceramide synthesis, filaggrin expression, epidermal thickness, collagen production, tropoelastin synthesis, and hyaluronic acid content simultaneously through the shared PPAR and oestrogen receptor signalling networks. The frequently reported experience of skin changing more rapidly in the 40–55 age range than in the preceding two decades reflects this hormonal convergence arriving on top of cumulative UV and chronological change rather than a sudden biological failure. ^[6]

Skin Health as a System

The implication for skin health strategy is that effective care – whether through professional treatment, homecare, or internal supplementation – requires a system-level understanding rather than component-level interventions in isolation.

Professional treatments reach different biological targets at different depths: thulium fractional laser and CAP act at the epidermal and papillary dermal level; RF microneedling reaches the reticular dermis; polynucleotides and iPRF deliver signals across both dermal zones; skin boosters restore the ground substance environment that fibroblast mechanosensitivity depends on; exosomes delivered via microneedling channels restore the epidermal differentiation programme at the basal level and DEJ. The most complete treatment protocols combine modalities to address multiple layers and mechanisms simultaneously, rather than selecting a single treatment for a single visible concern.

Homecare addresses the ongoing maintenance environment that determines whether professional treatment outcomes are preserved or progressively lost. Topical ceramide, cholesterol, and free fatty acid formulations support the barrier lipid triad. Vitamin C provides the cofactor for collagen hydroxylation and simultaneously reduces the MMP activity that degrades what fibroblasts produce. Retinoids normalise the keratinocyte differentiation cycle and upregulate TGF-β signalling in fibroblasts. Broad-spectrum UV protection prevents the primary upstream driver of MMP-driven structural degradation. Together, these do not treat skin, they maintain the biological conditions in which the skin can function, repair, and respond to professional treatment at its best capacity. ^[5]

Internal supplementation addresses the synthesis supply side and the inflammatory environment that suppresses it: phytoceramides through the salvage pathway, omega-3 fatty acids through IL-4/ IL-13 modulation, vitamin C through collagen synthesis cofactor support, and L-histidine as an NMF precursor. None replaces topical or professional approaches, but each contributes to a biological environment in which the skin’s own production capacity is less constrained. ^[4]